Partnering with Biotech Corporations for Strategic Investment 

Corporate venture capital can offer more than funding. It can unlock strategic partnerships, validation, and pathways to scale. Working with large biotech companies requires a different strategy.

Ian Goldstein, Partner at Fenwick will moderate a panel to include: 
- Olga Danilchanka, Partner at MRL Ventures at Merck
- Christine Brennan, Partner at Johnson & Johnson Development Corp.
- Jason Hafler, Managing Director at Sanofi Ventures

Join corporate VC leaders from top biotech organizations for a candid discussion on how life sciences founders can successfully raise capital and build meaningful partnerships.

By confirming your attendance you agree to receive communications and updates from Fenwick.

This event is a part of #BOSTechWeek—a week of events hosted by VCs and startups to bring together the tech ecosystem. Learn more at www.tech-week.com.

display

rXKLDOnF3yqW2hg9EEJnE

What financing stage best describes your company?

Are you planning to raise capital in the next 12 months?

What best describes your company’s focus?

Is your company currently raising capital or planning to within the next 12 months?

Partnering with Biotech for Strategic Investment - #BOSTechWeek

Guest List

Restricted Access